Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANS-6637 for Alcohol Use Disorder
NCT04311294Phase 2Withdrawn
- Sponsor
- University of California, Los Angeles
- Start
- Apr 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ANS-6637 in alcohol use disorder (AUD) (3 arms), sponsored by University of California, Los Angeles. Primary endpoints: Change in Subjective Response to Alcohol at 180 minutes and Change in Neural Alcohol Cue Reactivity at Day 4. Planned start Apr 2020; status: withdrawn.
02
Drugs
ANS-6637
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04311294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04311294.